维普中文期刊产品整合服务
424篇 您的检索式:作者名="Jacobson B"
    题名 作者 年代 出处 被引量
1Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis显示文摘AIM To confirm previous conclusions on Saccharomyces cerevisiae(S. cerevisiae) CNCM I-3856 for irritable bowel syndrome(IBS) management.METHODS An individual patient data meta-analysis was performed on two randomized clinical trials studying the effect of S. cerevisiae CNCM I-3856 supplementation on gastrointestinal(GI) symptoms in IBS subjects. A total of 579 IBS subjects were included. Outcomes were the daily Likert scale scores of abdominal pain/discomfort and bloating [area under the curve(AUC) and weekly means], responder status, and bowel movements(stool frequency and consistency). Statistical analyses were conducted in Intent to Treat(ITT) population, IBS-C subjects and IBS-C subjects with an abdominal pain/discomfort score higher than or equal to 2 at baseline('IBS-C ≥ 2 subpopulation').RESULTS S. cerevisiae CNCM I-3856 significantly improved abdominal pain/discomfort and bloating during the second month of supplementation [AUC(W5-W8)]with improvement up to the minimal clinically relevant threshold of 10%: a 12.3% reduction of abdominal pain/discomfort in the ITT population compared to the Placebo group(P = 0.0134) has been observed. In the IBS-C ≥ 2 subpopulation, there were a 13.1% reduction of abdominal pain/discomfort and a 14.9% reduction of bloating compared to the Placebo group(P = 0.0194 and P = 0.0145, respectively). GI symptoms significantly decreased during supplementation but no statistical differences were reported between groups at the end of the supplementation period. Responder status was defined as a subject who experienced a decrease of 1 arbitrary unit(a.u.) or 50% of the abdominal discomfort score from baseline for at least 2 wk out of the last 4 wk of the study. A significant difference between groups was reported in the ITT population, when considering the first definition: subjects in the Active group had 1.510 higher odds to be a responder(reduction of 1 a.u. of abdominal pain/discomfort) compared with subjects in the Placebo group(P = 0.0240). At the end of supplementation period, stool consistency in the Active group of the ITT population was significantly improved and classified as 'normal' compared to Placebo(respectively 3.13 ± 1.197 a.u. vs 2.58 ± 1.020 a.u., P = 0.0003). Similar results were seen in the IBS-C ≥ 2 subpopulation(Active group: 3.14 ± 1.219 a.u. vs Placebo group: 2.59 ± 1.017 a.u., P = 0.0009).CONCLUSION This meta-analysis supports previous data linking S. cerevisiae I-3856 and improvement of GI symptoms, in IBS overall population and in the IBS-C and IBS-C ≥ 2 subpopulations.Amélie Cayzeele-Decherf Fanny Pélerin Sébastien Leuillet Benoit Douillard Béatrice Housez Murielle Cazaubiel Gunnard K Jacobson Peter Jüsten Pierre Desreumaux 2017World Journal of Gastroenterology2017,23,2:2
2GABA(B(1)) receptor isoforms differentially mediate the acquisition and extinction of aversive taste memories 显示文摘Jacobson L H Kelly P H Bettler B 2006J Neurosci2006,26,34:1
3Selective antagonism of the hepatic glucocorticoid receptor reduces hepatic glucose production显示文摘Edgerton D S Jacobson P B Opgenorth T Jet cd 2006Metabolism2006,55,9:1
4The effect of pH and polyunsaturated C18 fatty acid source on the production of vaccenic acid and conjugated linoleic acids in ruminal cultures incubated with docosahexaenoic acid 显示文摘AbuGhazaleh A A Jacobson B N 2007Anim Feed Sci Technol2007,136,12:1
5Ultrasonic velocity in liquids and mixtures显示文摘JACOBSON B 1952J Chem Phys1952,20,:1
6C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats显示文摘Samnegard B Jacobson SH Johansson BL 2004Nephrol Dial Transplant2004,19,6:1
7Endoradiosonde 显示文摘Mackay R S Jacobson B 1957Nature1957,179,:1
8Diagnosis of thrombosis by catheter phlebography after prolonged central venous catheterization显示文摘Brismar B Hardstedt C Jacobson S 1981Ann Surg1981,194,:1
9Environmental factors determining the trace-level sorption of silver and thallium to soils显示文摘JACOBSON A R MCBRIDE M B BAVEYE P 2005Science of the Total Environment2005,345,123:1
10Chronic upper re spiratory tract disease of free-ranging desert tortoises(Xerobates agassizii)显示文摘Jacobson E R Gaskin J M Brown M B 1990J Wildl Dis1990,27,:1
11C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats显示文摘Samnegard B Jacobson SH Jaremko G 2005Nephrol Dial Transplant2005,20,3:1
12Prognostic value of HIV-1 RNA,CD4 cell count,and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1infection显示文摘Mellors J W Margolick J B Phair J P Rinaldo C R Detels R Jacobson L P Mu noz A 2007JAMA2007,297,21:1
13Development of the Tinnitus Handicap Inventory显示文摘NEWMAN C W JACOBSON G P SPITZER J B 1996Arch Otolaryngol Head Neck Surg1996,122,:1
14Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in southwest oncology group chemotherapy trials 显示文摘DURIE B G JACOBSON J BARLOGIE B 2004J Clin Oneol2004,22,10:1
15Psychosocial therapies in diabetes:report of the psychosocial therapies working group显示文摘 Jacobson AM Anderson B 2001Diabetes Care2001,24,2:1
16Differentiation of endoderm derivatives, pancreas and intestine,from rhesus embryonic stem cells显示文摘Jacobson L Kahan B Djamali A 2001Transplant Proc2001,33,12:1
17Ultrasonic velocity in liquids and liquid mixtures 显示文摘Jacobson B 1952J Chem Phy1952,20,:1
18The recency of technological in- puts and financial performance显示文摘Heeley M B Jacobson R 0,,07:1
19Bulk and micropatterned conjugation of extracellular matrix pro- teins to characterized polyacrylamide substrates for cell meehanotransduction assays显示文摘DAMLJANOVIC V LAGERHOLM B JACOBSON K 2005Short Technical Reports2005,39,6:1
20The effect of Tai Chi Chuan training on balance,kinesthetic sense and strength显示文摘Jacobson B H Chen H C Cashel C 1997Perceptual and Motor Skill1997,84,:1
返回顶部 每页显示:
共22页 首页 上一页 第1页 下一页 末页 /22 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费